Working Together for Meaningful Progress

We share a bold goal with our partners: to end scleroderma. Progress depends on collaboration, and our work with advocacy groups and industry leaders supports efforts to empower patients, inform researchers and clinicians, and advance scientific understanding of this complex disease.